Trial intelligence / Profile preview

ESP Block vs QL Block for Pediatric Postoperative Pain

NCT03463382Completed

Sponsor
Kocaeli University
Start
Mar 2018
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by Kocaeli University. Primary endpoint: Pain scores at 6 hours. Started Mar 2018; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03463382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03463382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call